LAZARD ASSET MANAGEMENT LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 214 filers reported holding BEAM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.7%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,461
-26.8%
60,790
-2.7%
0.00%0.0%
Q2 2023$1,995
+4.3%
62,490
-0.0%
0.00%
-33.3%
Q1 2023$1,913
-20.7%
62,505
+1.3%
0.00%0.0%
Q4 2022$2,412
-100.0%
61,689
-45.8%
0.00%
-62.5%
Q3 2022$5,423,000
+29.7%
113,852
+5.4%
0.01%
+33.3%
Q2 2022$4,181,000
+3.0%
108,032
+52.5%
0.01%
+20.0%
Q1 2022$4,059,000
-4.1%
70,850
+33.4%
0.01%0.0%
Q4 2021$4,233,000
+88.6%
53,128
+105.9%
0.01%
+66.7%
Q3 2021$2,245,000
-29.1%
25,806
+4.9%
0.00%
-25.0%
Q2 2021$3,165,000
+10450.0%
24,591
+6354.3%
0.00%
Q1 2021$30,0003810.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$189,105,00091.90%
PATHWAY CAPITAL MANAGEMENT, LP 37,399$2,993,00016.59%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,390$17,960,00010.54%
HSG Holding Ltd 796,089$63,719,0004.73%
DC Investments Management, LLC 21,010$1,682,0004.17%
Monashee Investment Management LLC 268,820$21,516,0003.31%
Redmile Group, LLC 2,532,523$202,703,0002.86%
HAMILTON LANE ADVISORS LLC 98,761$7,905,0002.58%
Alphabet Inc. 640,792$51,289,0002.07%
Casdin Capital, LLC 818,820$65,538,0001.95%
View complete list of BEAM THERAPEUTICS INC shareholders